PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer-related Fatigue|Neutropenia, Malignant
Interventions: DRUG: Astragalus polysaccharides 500 mg|DRUG: Placebo|PROCEDURE: EC Chemotherapy
Sponsor: PhytoHealth Corporation